# Topical Phenylephrine Solution in Preventing Oral Mucosa in Bone Marrow Transplant Patients Receiving Cyclophosphamide and Total Body Radiation Therapy

> **NCT02434146** · PHASE1,PHASE2 · TERMINATED · sponsor: **University of Wisconsin, Madison** · enrollment: 3 (actual)

## Conditions studied

- Neoplasm
- Oral Mucosa
- Transplant-Related Disorder

## Interventions

- **DRUG:** Topical Phenylephrine Solution

## Key facts

- **NCT ID:** NCT02434146
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-05-14
- **Primary completion:** 2016-04-27
- **Final completion:** 2017-01-25
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** A company in China has decided to license the product
- **Last updated:** 2019-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02434146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02434146, "Topical Phenylephrine Solution in Preventing Oral Mucosa in Bone Marrow Transplant Patients Receiving Cyclophosphamide and Total Body Radiation Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02434146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*